ATE412181T1 - Verbessertes verfahren zur diagnose des akuten koronarsyndroms - Google Patents

Verbessertes verfahren zur diagnose des akuten koronarsyndroms

Info

Publication number
ATE412181T1
ATE412181T1 AT05708124T AT05708124T ATE412181T1 AT E412181 T1 ATE412181 T1 AT E412181T1 AT 05708124 T AT05708124 T AT 05708124T AT 05708124 T AT05708124 T AT 05708124T AT E412181 T1 ATE412181 T1 AT E412181T1
Authority
AT
Austria
Prior art keywords
papp
free
prombp
complexed
acute coronary
Prior art date
Application number
AT05708124T
Other languages
English (en)
Inventor
Qiu-Ping Qin
Kim Pettersson
Original Assignee
Turun Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34826080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412181(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Turun Yliopisto filed Critical Turun Yliopisto
Application granted granted Critical
Publication of ATE412181T1 publication Critical patent/ATE412181T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Detection And Correction Of Errors (AREA)
  • Detection And Prevention Of Errors In Transmission (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05708124T 2004-01-28 2005-01-19 Verbessertes verfahren zur diagnose des akuten koronarsyndroms ATE412181T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53943104P 2004-01-28 2004-01-28

Publications (1)

Publication Number Publication Date
ATE412181T1 true ATE412181T1 (de) 2008-11-15

Family

ID=34826080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05708124T ATE412181T1 (de) 2004-01-28 2005-01-19 Verbessertes verfahren zur diagnose des akuten koronarsyndroms

Country Status (9)

Country Link
US (3) US7824876B2 (de)
EP (1) EP1709448B1 (de)
JP (1) JP4903585B2 (de)
CN (1) CN1934449A (de)
AT (1) ATE412181T1 (de)
CA (1) CA2549066C (de)
DE (1) DE602005010548D1 (de)
ES (1) ES2314624T3 (de)
WO (1) WO2005073727A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE412181T1 (de) * 2004-01-28 2008-11-15 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms
EP2309265B1 (de) * 2008-07-31 2013-07-17 Nitto Boseki CO., LTD. Verfahren zur untersuchung eines komplexes und darin zu verwendendes kit
FI20095733A0 (fi) 2009-06-29 2009-06-29 Hytest Oy IGFBP-4-fragmenttien määrittäminen diagnostisena menetelmänä
US20240103016A1 (en) 2020-12-09 2024-03-28 Gynuity Health Projects, Inc. Methods of detecting papp-a and related methods for gestational age assessment
CN113075406A (zh) * 2021-04-15 2021-07-06 江苏优尼泰克生物科技有限公司 用于妊娠相关性血浆蛋白a检测的组合物和磁微球电化学发光免疫检测试剂盒与检测方法
CN116042586A (zh) * 2022-12-23 2023-05-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠血浆papp-a复合物蛋白、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206354B (it) * 1977-03-10 1989-04-21 Lepetit Spa Corredo da usarsi per la determinazione degli ormoni liberi nei fluidi biologici
US4366143A (en) * 1979-09-24 1982-12-28 Amersham International Public Limited Company Assay for the free portion of substances in biological fluids
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
JPH10150999A (ja) * 1996-11-22 1998-06-09 Eiken Chem Co Ltd ヒト前立腺特異抗原−α１−アンチキモトリプシン複合体に対するモノクローナル抗体及びそれを用いたヒト前立腺特異抗原−α１−アンチキモトリプシン複合体の免疫学的検出法
JP4437211B2 (ja) * 1999-03-12 2010-03-24 アークレイ株式会社 免疫クロマトグラフィーを用いた測定方法およびそれに用いる検体分析用具
US7115382B1 (en) * 1999-03-15 2006-10-03 Mayo Foundation For Medical Education And Research Method for detecting IGFBP-4 protease without detecting IGFBP-4 protease/proMBP Complex
DE60034779T2 (de) * 1999-03-15 2008-01-17 Mayo Foundation For Medical Education And Research, Rochester Insulinartiger-wachstumsfaktorbindungsprotein-4-protease
FR2796952B1 (fr) * 1999-07-30 2003-08-15 Centre Nat Rech Scient Nouvelles applications de peptides issus du domaine cytoplasmique du precurseur de la proteine amyloide
CA2464121C (en) * 2000-10-20 2013-08-13 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
US6500630B2 (en) * 2001-01-12 2002-12-31 Mayo Foundation For Medical Education And Research Marker for inflammatory conditions
CA2330894A1 (en) * 2001-01-12 2002-07-12 Universite De Sherbrooke Optically aligned and network-stabilized ferroelectric liquid crystals using azobenzene-containing diacrylate monomers
ATE412181T1 (de) * 2004-01-28 2008-11-15 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms

Also Published As

Publication number Publication date
CA2549066A1 (en) 2005-08-11
CA2549066C (en) 2012-11-13
US7824876B2 (en) 2010-11-02
DE602005010548D1 (de) 2008-12-04
US20120264139A1 (en) 2012-10-18
WO2005073727A1 (en) 2005-08-11
ES2314624T3 (es) 2009-03-16
EP1709448A1 (de) 2006-10-11
US20070111254A1 (en) 2007-05-17
CN1934449A (zh) 2007-03-21
EP1709448B1 (de) 2008-10-22
US20110014631A1 (en) 2011-01-20
JP2007519913A (ja) 2007-07-19
JP4903585B2 (ja) 2012-03-28

Similar Documents

Publication Publication Date Title
IL252832A0 (en) Use of biomarkers for detecting ovarian cancer
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
ATE386936T1 (de) Selbst-kalibrierendes system für magnetisches bindungs-verfahren
DE60228557D1 (de) Candida-nachweis
DE60025347D1 (de) Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
MX2009006205A (es) Inmunoensayo de multiples analitos.
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE502005005132D1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
ATE412181T1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
ATE409314T1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und serumamyloid a
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
GB2456690A (en) A method for quantitative detection of diabetes related immunological markers
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
JP2005249567A5 (de)
SE0003662D0 (sv) Assay method and kit therefor
GB0501564D0 (en) Test for prion disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties